izopet
seropreval
key
factor
deconfin
franc
journal
infect
doi
http
doi
failur
anticip
spread
contain
phase
serious
threaten
mani
health
system
develop
method
measur
seropreval
affect
deconfin
strategi
franc
seropreval
must
least
confin
constraint
relax
deconfin
progress
order
avoid
rebound
epidem
seropreval
key
factor
deconfin
franc
dimeglio
jeanmichel
loub
new
viru
spread
worldwid
sinc
decemb
probabl
affect
million
peopl
kill
thousand
failur
anticip
spread
viru
serious
threaten
mani
health
system
design
model
predict
evolut
epidem
franc
base
seropreval
make
possibl
anticip
deconfin
strategi
keyword
seropreval
statist
model
deconfin
sever
acut
respiratori
syndrom
coronaviru
emerg
wuhan
china
decemb
spread
larg
sustain
humantohuman
transmiss
declar
result
diseas
pandem
viru
caus
sever
respiratori
ill
suscept
individu
spread
rapidli
threaten
satur
health
servic
particularli
intens
care
capac
present
concern
mainli
itali
spain
franc
countri
unit
state
may
well
succumb
difficult
predict
infect
spread
gener
popul
calibr
respons
epidem
must
take
account
number
case
includ
infect
asymptomat
individu
detect
due
lack
test
exist
model
base
publish
posit
case
take
account
either
peopl
age
evolut
diffus
coeffici
statist
model
predict
spread
franc
base
diffus
transmiss
coeffici
vari
individu
age
likelihood
contagion
two
administr
paramet
confin
quarantin
use
model
measur
dynam
infect
affect
differ
factor
adapt
deconfin
strategi
consid
variabl
defin
age
class
variabl
day
given
age
class
number
healthi
peopl
number
undetect
contagi
carrier
infect
day
similarli
number
detect
contagi
carrier
infect
day
day
mortal
rate
per
target
age
group
assum
risk
viruscaus
death
stage
infect
number
peopl
immun
die
given
age
class
defin
number
day
person
contagi
percentag
popul
test
day
number
healthi
peopl
contagi
person
contact
infect
assum
contagion
coeffici
vari
time
peak
viru
load
maxim
day
start
infect
total
popul
start
epidem
phase
multipli
pace
epidem
throughout
confin
multipli
quarantin
period
equal
confin
quarantin
phase
given
transit
day
day
model
discret
version
suscept
infecti
recov
sir
type
model
chosen
estim
initi
model
set
use
data
publish
john
hopkin
univers
franc
data
collect
toulous
virolog
laboratori
without
contain
preval
infect
march
may
figur
contain
began
march
franc
schedul
end
may
figur
c
show
predict
new
case
per
day
depend
seropreval
contain
phase
figur
b
indic
seropreval
march
contain
infect
rebound
may
howev
seropreval
begin
contain
figur
seropreval
may
would
infect
rebound
popul
contract
march
figur
would
infect
immun
dead
may
rebound
would
smaller
lastli
seropreval
contain
figur
e
almost
rebound
seropreval
may
conclud
seropreval
contain
phase
order
avoid
rebound
figur
assum
contain
end
complet
may
abolish
gradual
may
june
total
relax
juli
consid
progress
phase
consist
relax
restrict
contain
measur
seropreval
june
lead
rebound
end
juli
ideal
situat
shown
figur
b
progress
deconfin
phase
last
longer
may
octob
time
seropreval
reach
relax
restrict
date
lead
rebound
data
indic
seropreval
must
reach
approxim
total
deconfin
may
gradual
exit
phase
sever
month
start
may
infect
rebound
avoid
figur
figur
b
seropreval
franc
confin
phase
measur
march
probabl
possibl
determin
proport
popul
came
contact
viru
end
confin
phase
provid
basi
estim
size
infect
rebound
remain
highli
unlik
case
shown
figur
e
seropreval
appli
therefor
question
adapt
deconfin
strategi
reach
seropreval
gradual
avoid
rebound
may
requir
wear
mask
sever
month
predict
power
model
may
hamper
way
casualti
measur
strategi
use
detect
number
posit
case
postprocess
data
handl
bias
topic
futur
report
accord
seropreval
contain
contain
b
seropreval
c
seropreval
seropreval
e
seropreval
